ライフサイエンスコーパス: tissue engineering

1 ines, from microarrays and smart surfaces to tissue engineering.

2 arch, patient phenotyping, drug testing, and tissue engineering.

3 plied to therapeutic BAT transplantation and tissue engineering.

4 orable static or even dynamic interfaces for tissue engineering.

5 omaterials-an attractive approach for neural tissue engineering.

6 promoting enhanced wound healing and in skin tissue engineering.

7 med vascular beds has become a major goal of tissue engineering.

8 pplied to the wide range of systems used for tissue engineering.

9 sion are long-standing challenges in cardiac tissue engineering.

10 on and manufacturing nanofiber scaffolds for tissue engineering.

11 rgan human penile specimens for total penile tissue engineering.

12 harness the potential of MSCs for cartilage tissue engineering.

13 skeletal research, regeneration medicine and tissue engineering.

14 ent obstacles in disease modelling and liver tissue engineering.

15 s (10%) scaffolds for drug delivery and bone tissue engineering.

16 aining and simulations to mechanobiology and tissue engineering.

17 manufactured scaffold design for functional tissue engineering.

18 ave been integral for advancing the field of tissue engineering.

19 offering customized cell-based therapies for tissue engineering.

20 H)D3 has great potential for cell-based bone tissue engineering.

21 tro would represent an important advance for tissue engineering.

22 mmalian cells, with applications in cell and tissue engineering.

23 bal niche as culture matrices for epithelial tissue engineering.

24 ted NDs to develop a novel platform for bone tissue engineering.

25 long-standing challenge for stem cell-based tissue engineering.

26 properties very suitable to apply in corneal tissue engineering.

27 nging from advanced drug delivery systems to tissue engineering.

28 tion as a key design parameter for cartilage tissue engineering.

29 ces for drug delivery, cell manipulation and tissue engineering.

30 e fabrication of nanocomposite hydrogels for tissue engineering.

31 on is essential for the advancement of liver tissue engineering.

32 ymers were suggested as future materials for tissue engineering.

33 a step towards a humanized in vivo model for tissue engineering.

34 ined drug delivery, noninvasive imaging, and tissue engineering.

35 s, including 3D cell culture and micro-scale tissue engineering.

36 tem for the application of 3D bioprinting in tissue engineering.

37 ing, cell-cell fusion and communication, and tissue engineering.

38 otics, biomedical devices, drug delivery and tissue engineering.

39 ive diagnostic capabilities, biosensing, and tissue engineering.

40 potential applications in drug delivery and tissue engineering.

41 d the delivery of therapeutics and cells for tissue engineering.

42 describing Lab-on-a-chip systems for cardiac tissue engineering.

43 have been rarely explored in the context of tissue engineering.

44 n identifying suitable materials for cardiac tissue engineering.

45 abrication of 3D scaffolds intended for bone tissue engineering.

46 promising biomaterials for cell culture and tissue engineering.

47 and opportunities in tumour radiotherapy and tissue engineering.

48 very, detoxification, immune modulation, and tissue engineering.

49 has demonstrated utility in cell culture and tissue engineering.

50 tential cell source to consider for meniscus tissue engineering.

51 pan-tissue functional genetic screening, and tissue engineering.

52 ug delivery carriers, in bioelectronics, and tissue engineering.

53 elivery, biosensors, nerve regeneration, and tissue engineering.

54 graft and BMP products used commonly in bone tissue engineering.

55 ulation of angiogenesis in wound healing and tissue engineering.

56 C16)-RGD is a promising material for cardiac tissue engineering.

57 e alternative to growth factors in cartilage tissue engineering.

58 theranostics, drug delivery, biosensing, and tissue engineering.

59 rting to three-dimensional (3D) printing and tissue engineering.

60 Tissue engineering, a recent promising way to possibly r

61 ily low concentrations, with applications in tissue engineering, agriculture, water purification and

62 Tissue engineering aims to utilise biologic mediators to

63 An optimal material for cardiac tissue engineering, allowing cardiomyocyte attachment an

64 tainability and energy harvesting/storage to tissue engineering and additive manufacturing.

65 interactions are achieved in development and tissue engineering and altered in disease and evolution.

66 ollagen-based hydrogels are commonly used in tissue engineering and as matrices for biophysical studi

67 combination of techniques from 3D printing, tissue engineering and biomaterials has yielded a new cl

68 Biocompatible polymers are widely used in tissue engineering and biomedical device applications.

69 new avenue in biomaterial design to advance tissue engineering and cell delivery.

70 ich will be of significant use in a range of tissue engineering and cell mechanosensing studies.

71 , as well as providing a source of cells for tissue engineering and cell therapy approaches.

72 em cells (hPSCs) offer tremendous promise in tissue engineering and cell-based therapies because of t

73 em cells (hPSCs) offer tremendous promise in tissue engineering and cell-based therapies due to their

74 asing use of methacrylate-based materials in tissue engineering and dental restorations demands detai

75 research topic; because their application in tissue engineering and disease modeling have great poten

76 nd potentially patient-specific platform for tissue engineering and drug delivery.

77 ive hydrogels have potential applications in tissue engineering and drug delivery.

78 ese miniaturized systems very attractive for tissue engineering and drug screening applications.

79 the way for the application of organoids for tissue engineering and liver transplantation.

80 creening drugs, in particular, for interface tissue engineering and modeling.

81 cs, suggesting new therapeutic approaches in tissue engineering and PDLMSCs are more appropriate cand

82 enges that must be addressed in the field of tissue engineering and provide a perspective regarding s

83 ogress has been made in the fields of dental tissue engineering and regenerative dental medicine, col

84 has benefited from the more mature field of tissue engineering and regenerative medicine (TERM), est

85 le hydrogels should find use in a variety of tissue engineering and regenerative medicine application

86 acrophage balance and properly exploit it in tissue engineering and regenerative medicine application

87 onal porous scaffolds play a pivotal role in tissue engineering and regenerative medicine by function

88 The field of tissue engineering and regenerative medicine has made nu

89 We then showcase their broad applications in tissue engineering and regenerative medicine, followed b

90 cal research, creating new opportunities for tissue engineering and regenerative medicine, generating

91 and driven numerous pivotal advancements in tissue engineering and regenerative medicine.

92 (MSCs), strong candidates for fields such as tissue engineering and regenerative medicine.

93 ucible biomaterials with applications across tissue engineering and regenerative medicine.

94 tissue and are widely used biomaterials for tissue engineering and regenerative medicine.

95 a mat will have wide utility in the areas of tissue engineering and regenerative medicine.

96 omplex biological constructs in the field of tissue engineering and regenerative medicine.

97 e for biomedical applications, especially in tissue engineering and regenerative medicine.

98 l scaffolds have served as the foundation of tissue engineering and regenerative medicine.

99 intense debate and interest in the field of tissue engineering and regenerative studies include the

100 is highly important for novel approaches in tissue engineering and repair.

101 or therapeutic delivery, precision medicine, tissue engineering and stem cell therapy.

102 fundamental concepts associated with muscle-tissue engineering and the current status of muscle-tiss

103 factors to the CNS, opening a new avenue for tissue engineering and the treatment of CNS disorders an

104 thodologies will enable new opportunities in tissue engineering and therapeutic delivery.

105 f gene delivery, drug delivery, bio-imaging, tissue engineering, and antimicrobials.

106 e use of NDs in the fields of drug delivery, tissue engineering, and bioimaging.

107 ture for disease modeling, drug testing, and tissue engineering, and conclude with an outlook on the

108 c cardiac subpopulations for drug screening, tissue engineering, and disease modeling.

109 ytes, which are critical for drug screening, tissue engineering, and disease modeling.

110 gical applications, including immunotherapy, tissue engineering, and drug delivery.

111 the increasing demand of stem cell research, tissue engineering, and drug screening.

112 s in genome editing, cellular reprogramming, tissue engineering, and information technologies, especi

113 bining their knowledge of biology, medicine, tissue engineering, and microtechnology to develop new e

114 may be implemented in regenerative medicine, tissue engineering, and pharmaceutical safety and effica

115 and delivery of materials in pharmaceutics, tissue engineering, and photonics.

116 erapeutic strategies including cell therapy, tissue engineering, and regenerative medicine and are fr

117 ased bioprinting for in vitro tissue models, tissue engineering, and regenerative medicine are provid

118 iverse as electronics, structural materials, tissue engineering, and soft robotics.

119 g to enable new studies in organoid science, tissue engineering, and spatially targeted cell therapie

120 quired for various biomedical fields such as tissue-engineering, anti-fouling coating, and implantabl

121 d system (CM-ALs) for drug delivery and bone tissue engineering application.

122 nd application of nanocomposite hydrogels in tissue engineering applications are described, with spec

123 Biomaterial development for tissue engineering applications is rapidly increasing bu

124 ical devices, such as biosensors, as well as tissue engineering applications where both a vascularize

125 ential to produce personalized scaffolds for tissue engineering applications with unprecedented contr

126 ng the use of CPs for wound healing and skin tissue engineering applications, in particular the most

127 For bone tissue engineering applications, tissue collection typic

128 ce acellular urethra bioscaffolds for future tissue engineering applications, using bioscaffolds or b

129 oaded conduits attractive for cardiovascular tissue engineering applications.

130 e a novel target in manipulating hASC for in tissue engineering applications.

131 expansion for large-scale drug screening and tissue engineering applications.

132 reening system useful for drug screening and tissue engineering applications.

133 an injectable material for cell delivery and tissue engineering applications.

134 readily tailored to different biomedical and tissue engineering applications.

135 models, treatments of myopathies, and other tissue engineering applications.

136 ve polymers attractive for drug delivery and tissue engineering applications.

137 ew biomaterial formulations for craniofacial tissue engineering applications.

138 ancer and stem cell research, as well as for tissue engineering applications.

139 drug delivery, gene therapy, biosensors, and tissue engineering applications.

140 orming future studies of vascularization and tissue engineering applications.

141 ve great potential in preparing implants for tissue engineering applications.

142 que opportunities for controlled-release and tissue-engineering applications.

143 architectures, demonstrating feasibility for tissue-engineering applications.

144 ting them as potentially good candidates for tissue-engineering applications.

145 c community is focused on the application of tissue engineering approach for the fertility restoratio

146 We used a tissue-engineering approach with embryonic and induced p

147 Tissue engineering approaches are emerging as alternativ

148 Cell and tissue engineering approaches for articular cartilage re

149 ical roles and potential for stem cell-based tissue engineering approaches have not been comprehensiv

150 Most tissue engineering approaches have tried to improve the

151 The use of tissue engineering approaches in combination with exogen

152 uded to inform the development of innovative tissue engineering approaches.

153 engineering and the current status of muscle-tissue-engineering approaches is provided.

154 The application of tissue-engineering approaches to human induced pluripote

155 However, many hurdles need to be overcome in tissue-engineering approaches, and clinical and regulato

156 gies in neural, skin, connective, and muscle tissue engineering are explored.

157 rging phenomena in developmental biology and tissue engineering are the result of feedbacks between g

158 fields, such as 3D bioprinting and bottom-up tissue engineering, as well as drug discovery, developme

159 cations of BOEC: their use for gene therapy, tissue engineering, assessment of mutant gene effect, an

160 In tissue engineering, autofluorescence of polymer scaffold

161 drug screening is particularly important in tissue engineering because of the high frequency of drug

162 sed hydrogels are increasingly attractive in tissue engineering because they provide a xeno-free, bio

163 llow for a range of in vitro applications in tissue engineering, bioelectronics, and diagnostics.

164 tatic cancer, these studies are relevant for tissue engineering, biological effects of materials, tis

165 An emerging challenge in tissue engineering biomimetic models is recapitulating t

166 variety of biomedical applications including tissue engineering, biomolecule delivery, cell delivery,

167 es to fabrication of nSC composites for bone tissue engineering (BTE) have limited capacity to achiev

168 tive dentistry, particularly for whole-tooth tissue engineering, builds on many key successes over th

169 ere we present a notable advance in vascular tissue engineering by generating the first functional 3-

170 nipulation for applications in areas such as tissue engineering can require mesoscale structures to b

171 Tissue-engineering can serve as an alternative to conven

172 t of such organotypic cultures has impact in tissue engineering, cancer therapy and personalized medi

173 ial joint autoimmune disease and injury) and tissue engineering (cell migration in engineered biomate

174 iomedical applications, especially for liver tissue engineering, cell preservation, and drug toxicity

175 In cardiac tissue engineering cells are seeded within porous biomat

176 This technique can be used for tissue engineering, cells actuation and drug discovery a

177 asive detachment of cells, in particular for tissue engineering, clinical applications and the use of

178 of biomineralization for intact real-size 3D tissue engineering constructs.

179 microenvironments on biomaterials or within tissue engineering constructs.

180 ld facilitate the next generation of cardiac tissue engineering design.

181 ney organoids to facilitate applications for tissue engineering, disease modeling and chemical screen

182 rs (TFs) is a powerful and exciting tool for tissue engineering, disease modeling, and regenerative m

183 applications in cementitious materials, bone-tissue engineering, drug delivery and refractory materia

184 ynthesize microparticles for mechanosensing, tissue engineering, drug delivery, energy storage, and d

185 myocytes (CMs) for cell replacement therapy, tissue engineering, drug discovery and toxicity screenin

186 oriented research topics, electrophysiology, tissue engineering, drug release, biosensing, and molecu

187 The application of bioprinting technology in tissue engineering enables the development of a 3D biomi

188 appropriate biomaterials impacts success in tissue engineering endeavors.

189 s one of the most critical challenges facing tissue-engineering experts in their attempt to create th

190 Many applications in tissue engineering, flexible electronics, and soft robot

191 toward the real-life application of cardiac tissue engineering for disease modeling, drug developmen

192 ng approach for xeno-free corneal epithelial tissue engineering for ocular surface reconstruction.

193 Advances in tissue engineering for urethral replacement have resulte

194 otent stem cell (iPSC)-based disease models, tissue engineering, gene therapy, and drug discovery.

195 Tissue engineering, gene therapy, drug screening, and em

196 The field of tissue engineering has advanced over the past decade, bu

197 lication of rapid, digital 3D bioprinting to tissue engineering has allowed 3D patterning of multiple

198 However, the field of tissue engineering has been growing exponentially in the

199 Tissue engineering has gained considerable attention in

200 Cell-based tissue engineering has recently been introduced, and res

201 The past 30 years of tissue engineering has resulted in the development of se

202 New strategies for tissue engineering have great potential for restoring an

203 iomyocytes provide a cell source for cardiac tissue engineering; however, their immaturity limits the

204 especially for stem cell differentiation and tissue engineering, if CARS/SHG microscopy is to be used

205 omising therapeutic strategy for dentin/pulp tissue engineering in future endodontic treatment.

206 ing new therapeutic strategy for dentin/pulp tissue engineering in future endodontic treatment.

207 s progress has been achieved in the field of tissue engineering in the past decade.

208 ineering MSC behavior for bone and cartilage tissue engineering, including gene delivery, gene editin

209 Cardiac tissue engineering is a promising approach to treat card

210 Expertise in organoid culture and tissue engineering is desirable for optimal results.

211 Therefore, tissue engineering is emerging as an alternative approac

212 Current research in penile tissue engineering is largely restricted to rodent and r

213 Tissue engineering is one of the most prominent examples

214 A challenge for tissue engineering is producing three-dimensional (3D),

215 move forward in the field, a new pathway in tissue engineering is proposed.

216 A major challenge in tissue engineering is the development of materials that

217 One goal of cardiac tissue engineering is the generation of a living, human

218 The goal of tissue engineering is to mitigate the critical shortage

219 The primary aim in tissue engineering is to repair, replace, and regenerate

220 cularized characteristics over BMP-2 in bone tissue engineering, is highlighted, which lays the groun

221 and poor functional vascularization in bone tissue engineering lead to lack of tissue integration an

222 larization for the clinical applicability of tissue engineering, many approaches have been investigat

223 ims to alleviate the hurdles of conventional tissue engineering methods by precise and controlled lay

224 ent state-of-the-art biomedical implants and tissue engineering methods promise technologies to impro

225 d systems using three-dimensional organoids, tissue-engineering, microfluidic organ-chips, and humani

226 rethra is a challenge for which the field of tissue engineering might offer promising solutions.

227 anotechnology and 3D bioprinting to urethral tissue engineering might present solutions to these issu

228 Tissue engineering of a transplantable liver could provi

229 Tissue engineering of penile tissue should focus on two

230 Technological impact is expected in the tissue engineering of periosteum for treating bone defec

231 nge of applications including biointerfaces, tissue engineering, optics/photonics, and bioelectronics

232 ing outcomes in the fields of drug delivery, tissue engineering or regenerative medicine.

233 ar and mechanical regulators on development, tissue engineering, or tumor progression.

234 ing the exsanguinous metabolic support (EMS) tissue-engineering platform.

235 e, this method can also be incorporated into tissue engineering platforms in which depletion of the s

236 eutic agents or stem cells, indicating their tissue engineering potential.

237 ucting polymers (CPs) in wound care and skin tissue engineering presents a novel opportunity for acce

238 A typical tissue-engineering process involves the design and fabri

239 city, an ability that can be used to monitor tissue engineering processes for applications in regener

240 the generation of urethra bioscaffold-based Tissue Engineering products.

241 As the field of tissue engineering progresses ever-further toward realiz

242 otential to improve cartilage generation for tissue engineering purposes and also to provide context

243 Fibrous scaffolds are used for bone tissue engineering purposes with great success across a

244 in vitro for biomimetic and cell-compatible tissue engineering purposes.

245 d cells as starting materials, in particular tissue engineering, regenerative medicine and also in th

246 well as their applications in drug delivery, tissue engineering, regenerative medicine and immunology

247 a range of biomedical applications including tissue engineering, regenerative medicine, and cell and

248 ically relevant areas such as drug delivery, tissue engineering, regenerative medicine, and soft robo

249 ations as advanced materials in biomedicine, tissue engineering, renewable energy, environmental scie

250 ss this problem, we demonstrate that modular tissue engineering results in an s.c. vascularized bed t

251 available technology to fabricate customized tissue engineering scaffolds with delicate architecture.

252 g them potentially ideal surgical grafts and tissue engineering scaffolds.

253 Cs and hence, would be beneficial for neural tissue engineering scaffolds.

254 for nondestructive characterization of bone tissue engineering scaffolds.

255 the field of advanced paper or as bioactive tissue engineering scaffolds.

256 roperties is a promising platform for future tissue-engineering scaffolds and biomedical applications

257 h as drug delivery, macroscopic injectables, tissue-engineering scaffolds, and nano-imaging agents.

258 In tissue engineering scenarios, after implantation of any

259 easingly important as the next generation of tissue engineering seeks to produce inhomogeneous constr

260 em cell research, regenerative medicine, and tissue engineering seems a promising approach to produce

261 optical coding, drug delivery, diagnostics, tissue engineering, shear-induced gelation, and function

262 However, advances in penile tissue engineering show great promise and, in combinatio

263 d bio-integrated electronics, microfluidics, tissue engineering, soft robotics and biomedical devices

264 d for applications such as medical implants, tissue engineering, soft robotics, and wearable electron

265 In tissue engineering, stem cells are widely employed to cr

266 as well as a discussion of state-of-the-art tissue engineering strategies and technologies that are

267 c growth factors (GFs) is one of alternative tissue engineering strategies for osteochondral tissue r

268 al tissue strength to guide future cartilage tissue engineering strategies for surgical reconstructio

269 Cardiac tissue engineering strategies have the potential to rege

270 ressed in the early phase of healing in oral tissue engineering strategies.

271 OA, have the potential to be repaired using tissue engineering strategies; however, it remains chall

272 Contemporary tissue-engineering strategies enable the seeding of a bi

273 rather than the cells themselves, and use of tissue-engineering strategies to provide structural supp

274 y demonstrates the feasibility of applying a tissue engineering strategy towards the development of s

275 didate as a safe, efficacious pediatric bone tissue engineering strategy.

276 Significantly, a five-week tissue engineering study demonstrated that printed oMSCs

277 re prospects in the field of bioprinting for tissue engineering (TE) and regenerative medicine (RM).

278 tentially applicable as scaffolds in cardiac tissue engineering (TE).

279 veloped using modern material processing and tissue engineering techniques.

280 ell as development of cancer diagnostics and tissue engineering technologies.

281 s in filtration, sensing, drug delivery, and tissue engineering that often require the fibers to be p

282 ontrol is highly significant for bioscaffold tissue engineering, the evolution of bone microarchitect

283 bariatric interventions, drug delivery, and tissue engineering.The use of drug delivery systems for

284 readily applied to a major target in complex tissue engineering: the osteochondral interface.

285 have found many biomedical applications for tissue engineering, therapeutics, and molecular imaging.

286 Tissue engineering TMJ discs has emerged as an alternati

287 anics with a wide range of applications from tissue engineering to nanoarchitected materials.

288 he feasibility and applicability of this new tissue engineering tool in psychiatry.

289 iency, motivating novel therapies, including tissue-engineering toward TMJ disc regeneration.

290 discuss the various concepts of heart valve tissue engineering underlying the design of next-generat

291 Tissue engineering using cardiomyocytes derived from hum

292 Tissue engineering using different cell types and tissue

293 Tissue engineering using whole, intact cell sheets has s

294 In contrast to a top-down method of tissue engineering where the differentiation of cells is

295 A researcher trained in the principles of tissue engineering will be able to execute the protocol

296 an overview on current strategies of cardiac tissue engineering with a focus on different hydrogel me

297 ed to develop therapeutic strategies in bone tissue engineering with numerable clinical applications.

298 ly involved in drug delivery, biosensing and tissue engineering, with strong contributions to the who

299 Implementing the principles of tissue engineering within the clinical management of non

300 d medical applications (e.g., drug delivery, tissue engineering, wound repair, etc.) through judiciou